Free Trial

Vanda Pharmaceuticals (VNDA) Short Interest Ratio & Short Volume

$4.98
-0.25 (-4.78%)
(As of 05/28/2024 ET)

Vanda Pharmaceuticals Short Interest Data

Current Short Interest
2,800,000 shares
Previous Short Interest
2,300,000 shares
Change Vs. Previous Month
+21.74%
Dollar Volume Sold Short
$15.01 million
Short Interest Ratio
1.2 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
58,200,000 shares
Float Size
55,080,000 shares
Short Percent of Float
5.08%
Today's Trading Volume
1,067,568 shares
Average Trading Volume
1,877,617 shares
Today's Volume Vs. Average
57%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Vanda Pharmaceuticals ?

Sign up to receive the latest short interest report for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VNDA Short Interest Over Time

VNDA Days to Cover Over Time

VNDA Percentage of Float Shorted Over Time

Vanda Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20242,800,000 shares $15.01 million +21.7%5.1%1.2 $5.36
4/30/20242,300,000 shares $10.95 million +11.1%4.2%1 $4.76
4/15/20242,070,000 shares $8.40 million -16.9%3.8%0.9 $4.06
3/31/20242,490,000 shares $10.23 million -17.0%4.6%1.3 $4.11
3/15/20243,000,000 shares $11.43 million -7.4%5.5%3.1 $3.81
2/29/20243,240,000 shares $14.48 million +9.5%6.0%3.2 $4.47
2/15/20242,960,000 shares $12.94 million +29.3%5.4%3 $4.37
1/31/20242,290,000 shares $8.24 million +30.9%N/A2.3 $3.60
1/15/20241,750,000 shares $6.74 million +1.2%N/A1.9 $3.85
12/31/20231,730,000 shares $7.30 million -9.0%N/A1.9 $4.22
12/15/20231,900,000 shares $7.37 million -8.2%N/A2.1 $3.88
11/30/20232,070,000 shares $7.70 million +1.5%N/A1.7 $3.72
11/15/20232,040,000 shares $7.24 million +21.4%N/A1.6 $3.55
10/31/20231,680,000 shares $7.36 million +0.6%N/A1.4 $4.38
10/15/20231,670,000 shares $7.10 million +10.6%N/A1.4 $4.25
9/30/20231,510,000 shares $6.52 million -64.1%3.1%1.3 $4.32
9/15/20234,210,000 shares $19.79 million +50.4%N/A3.8 $4.70
8/31/20232,800,000 shares $14.53 million +5.3%5.0%3.6 $5.19
8/15/20232,660,000 shares $15.88 million +18.2%4.8%4.5 $5.97
7/31/20232,250,000 shares $13.01 million +5.6%4.1%3.7 $5.78
7/15/20232,130,000 shares $12.84 million -5.8%3.8%3.8 $6.03
6/30/20232,260,000 shares $14.89 million -20.1%4.1%4 $6.59
6/15/20232,830,000 shares $17.94 million No Change5.1%5 $6.34
5/31/20232,830,000 shares $16.84 million -1.1%5.1%4.9 $5.95
5/15/20232,860,000 shares $18.08 million +1.8%5.2%5 $6.32
4/30/20232,810,000 shares $17.25 million -2.1%5.1%4.9 $6.14
4/15/20232,870,000 shares $18.54 million -8.0%5.3%5.1 $6.46
3/31/20233,120,000 shares $21.18 million +18.6%5.7%5.4 $6.79
3/15/20232,630,000 shares $16.81 million +8.2%4.8%4.2 $6.39
2/28/20232,430,000 shares $15.65 million +13.6%4.5%3.4 $6.44
2/15/20232,140,000 shares $14.96 million +7.0%3.9%3.2 $6.99
1/31/20232,000,000 shares $15.36 million +3.6%3.7%3.1 $7.68
1/15/20231,930,000 shares $14.80 million +0.5%3.6%3.1 $7.67
12/30/20221,920,000 shares $14.19 million +4.9%3.5%3.2 $7.39
12/15/20221,830,000 shares $12.77 million -20.8%3.4%3.3 $6.98
11/30/20222,310,000 shares $25.20 million -4.9%4.2%6.4 $10.91
11/15/20222,430,000 shares $25.93 million +2.5%4.5%6.4 $10.67
10/31/20222,370,000 shares $24.81 million -2.1%4.4%6.1 $10.47
10/15/20222,420,000 shares $23.74 million +0.8%4.5%6.2 $9.81
9/30/20222,400,000 shares $23.71 million +1.3%4.4%6.2 $9.88
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade
9/15/20222,370,000 shares $24.03 million +1.7%4.4%5.6 $10.14
8/31/20222,330,000 shares $24.65 million +0.4%4.3%5 $10.58
8/15/20222,320,000 shares $24.34 million +3.6%4.3%5.1 $10.49
7/31/20222,240,000 shares $24.15 million -10.0%4.1%4.5 $10.78
7/15/20222,490,000 shares $28.56 million -41.4%4.6%4.7 $11.47
6/30/20224,250,000 shares $46.33 million +3.2%7.9%7.7 $10.90
6/15/20224,120,000 shares $39.72 million -1.9%8.1%7.8 $9.64
5/31/20224,200,000 shares $41.29 million -8.7%7.8%8.6 $9.83
5/15/20224,600,000 shares $46.05 million +9.8%8.5%8.6 $10.01
4/30/20224,190,000 shares $41.56 million +2.0%7.7%6.8 $9.92
4/15/20224,110,000 shares $46.69 million +1.7%7.7%7 $11.36
3/31/20224,040,000 shares $45.69 million -3.6%7.5%7 $11.31
3/15/20224,190,000 shares $47.10 million +6.1%7.8%7.6 $11.24
2/28/20223,950,000 shares $44.87 million -10.0%7.4%6.8 $11.36
2/15/20224,390,000 shares $61.20 million +19.0%8.2%7.8 $13.94
1/31/20223,690,000 shares $55.94 million -4.7%6.9%7.2 $15.16
1/15/20223,870,000 shares $58.05 million +5.7%7.2%8.1 $15.00
12/31/20213,660,000 shares $57.43 million -2.7%6.8%7.7 $15.69
12/15/20213,760,000 shares $62.68 million -5.1%7.0%8 $16.67
11/30/20213,960,000 shares $64.15 million -5.3%7.4%9.1 $16.20
11/15/20214,180,000 shares $73.69 million -15.4%7.8%10 $17.63
10/29/20214,940,000 shares $84.57 million +2.5%9.2%12 $17.12
10/15/20214,820,000 shares $88.74 million +2.1%9.0%12.2 $18.41
9/30/20214,720,000 shares $80.90 million -0.4%8.8%12.6 $17.14
9/15/20214,740,000 shares $77.45 million -3.1%8.9%10.7 $16.34
8/31/20214,890,000 shares $81.86 million +5.4%9.1%10.8 $16.74
8/13/20214,640,000 shares $76.42 million -14.4%8.7%10 $16.47
7/30/20215,420,000 shares $88.40 million +1.1%10.1%11.5 $16.31
7/15/20215,360,000 shares $103.72 million +11.4%10.0%12.5 $19.35
6/30/20214,810,000 shares $103.46 million -3.6%9.0%11.2 $21.51
6/15/20214,990,000 shares $96.71 million +1.8%9.3%12.7 $19.38
5/28/20214,900,000 shares $86.68 million -1.2%9.2%12.2 $17.69
5/14/20214,960,000 shares $91.31 million -2.8%N/A11.7 $18.41
4/30/20215,100,000 shares $85.12 million -3.0%N/A9.3 $16.69
4/15/20215,260,000 shares $86.53 million -0.2%N/A9.6 $16.45
3/31/20215,270,000 shares $78.42 million +7.6%10.0%9.2 $14.88
3/15/20214,900,000 shares $87.76 million -4.7%9.3%8.6 $17.91
2/26/20215,140,000 shares $99.46 million -9.5%9.8%9.2 $19.35
2/12/20215,680,000 shares $106.05 million +0.4%10.8%10.3 $18.67
1/29/20215,660,000 shares $82.69 million -4.4%10.8%13 $14.61
1/15/20215,920,000 shares $82.76 million -4.5%11.3%12.9 $13.98
12/31/20206,200,000 shares $82.40 million -4.0%11.8%13.5 $13.29
12/15/20206,460,000 shares $84.37 million +7.3%12.3%13.1 $13.06
11/30/20206,020,000 shares $74.71 million -2.0%11.4%11.6 $12.41
10/30/20206,170,000 shares $67.81 million +6.6%11.7%10.8 $10.99
10/15/20205,790,000 shares $62.01 million -2.9%11.0%10 $10.71
9/30/20205,960,000 shares $57.57 million -4.3%11.3%9.8 $9.66
9/15/20206,230,000 shares $59.99 million -3.3%11.8%10.2 $9.63
8/31/20206,440,000 shares $66.27 million +6.1%12.2%10.1 $10.29
8/14/20206,070,000 shares $70.84 million +0.8%11.5%9.1 $11.67
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade
7/31/20206,020,000 shares $60.68 million -0.3%11.5%9 $10.08
7/15/20206,040,000 shares $71.33 million -3.1%11.5%9 $11.81
6/30/20206,230,000 shares $69.90 million +5.4%11.9%9 $11.22
6/15/20205,910,000 shares $65.72 million +18.7%11.3%7.9 $11.12
5/29/20204,980,000 shares $55.03 million +9.0%9.5%6.2 $11.05
5/15/20204,570,000 shares $52.37 million +5.8%8.8%5.6 $11.46
4/30/20204,320,000 shares $51.19 million -6.3%8.3%5.5 $11.85
4/15/20204,610,000 shares $48.04 million -1.9%8.8%5.8 $10.42
3/31/20204,700,000 shares $48.69 million +2.6%9.1%6.2 $10.36
3/13/20204,579,700 shares $52.07 million -4.8%8.9%4.9 $11.37
2/28/20204,810,000 shares $38.77 million +1.1%9.3%8 $8.06
2/14/20204,760,000 shares $51.22 million +6.0%9.2%8.5 $10.76
1/31/20204,490,000 shares $50.83 million +9.8%8.7%8.2 $11.32
1/15/20204,090,000 shares $55.09 million +2.0%7.9%7.3 $13.47
12/31/20194,010,000 shares $57.30 million -10.3%7.8%7.2 $14.29

VNDA Short Interest - Frequently Asked Questions

What is Vanda Pharmaceuticals' current short interest?

Short interest is the volume of Vanda Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 2,800,000 shares of VNDA short. 5.08% of Vanda Pharmaceuticals' shares are currently sold short. Learn More on Vanda Pharmaceuticals' current short interest.

What is a good short interest ratio for Vanda Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VNDA shares currently have a short interest ratio of 1.0. Learn More on Vanda Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Vanda Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.08% of Vanda Pharmaceuticals' floating shares are currently sold short.

Is Vanda Pharmaceuticals' short interest increasing or decreasing?

Vanda Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,800,000 shares, an increase of 21.7% from the previous total of 2,300,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Vanda Pharmaceuticals' float size?

Vanda Pharmaceuticals currently has issued a total of 58,200,000 shares. Some of Vanda Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vanda Pharmaceuticals currently has a public float of 55,080,000 shares.

How does Vanda Pharmaceuticals' short interest compare to its competitors?

5.08% of Vanda Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vanda Pharmaceuticals: XOMA Co. (2.09%), Verastem, Inc. (3.94%), Emergent BioSolutions Inc. (11.97%), Lexicon Pharmaceuticals, Inc. (9.45%), Rigel Pharmaceuticals, Inc. (3.22%), Gossamer Bio, Inc. (5.56%), Regulus Therapeutics Inc. (5.44%), VBI Vaccines Inc. (1.18%), AnaptysBio, Inc. (18.36%), OPKO Health, Inc. (26.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Vanda Pharmaceuticals stock?

Short selling VNDA is an investing strategy that aims to generate trading profit from Vanda Pharmaceuticals as its price is falling. VNDA shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vanda Pharmaceuticals?

A short squeeze for Vanda Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VNDA, which in turn drives the price of the stock up even further.

How often is Vanda Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VNDA, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:VNDA) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners